Altogether, these results demonstrate that RBM4-S plays an opposite role as compared to the canonical tumor suppressor RBM4-FL, therefore, the splicing switch towards RBM4-S is partially responsible for AURKA-regulated tumor growth. The gene discussed is RBM4; the disease is neoplasm.